Spatial Characteristics of the Immune Microenvironment in Brain Metastases Provide Critical Insights for Developing Predictive Markers for Anti-PD-1 Therapy
Brain metastases (BrM) exhibit variable intracranial responses to immune checkpoint blockade (ICB), and reliable biomarkers of benefit remain uncertain, possibly reflecting the distinctive brain microenvironment. This review discusses multiplex protein imaging, array-based spatial transcriptomics, and in situ RNA imagi...